Newsletters


 

The Regulation Digest

 

A weekly compendium of regulatory policy, news, and analysis.

 

SUBSCRIBE TODAY!


This week's edition...

 

 

May 5, 2021 -- Volume 10, Number 17

Features rulemaking activity related to COVID-19 by ED and CMS. Plus other notable actions by DOL, EPA, DOT, DHS, OMB, FDA, and DEA.

With opinions and analysis from Veronique de Rugy, Courtney Joslin, Cass Sunstein, Jennifer Schulp, Fernando Hernandez-Lepe, Martha Fedorowicz, Jonathan Adler, Adam Thierer, Eli Lehrer, Robert Graboyes, David Michaels, Richard Pierce, Tala Al Jabri, Dan Farber, Wayne Crews, Matthew Mitchell, and Don Boudreaux.

Plus news from Roll CallThe HillNew York TimesReutersWall Street JournalAssociated Press, and Bloomberg.



Photo of Roslyn Layton

Dr. Roslyn Layton

Visiting Scholar
American Enterprise Institute

"The Regulation Digest is better than an algorithm."



Photo of Adam White.

Adam J. White

Executive Director
Center for the Study of the Administrative State

"I recommend everyone subscribe to the Regulation Digest. It's really indispensable."


Previous editions

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CFPB, ED, FDA, HRSA, and CBP. Plus other notable actions by DHS, EPA, Commerce, FERC, and DOE.

With opinions and analysis from Bridget Dooling, Laura Stanley, Zhoudan Xie, Howard Beales, Josiah Neeley, Joseph Aldy, Matthew Adler, Sandeep Jauhar, Nicole Cimbura, Gilbert Metcalf, Lawrence Goulder, Christopher Walker, Robert Atkinson, Samantha Gross, Kent Lassman, and Sarah Ladin.

Plus news from The HillNew York TimesWall Street JournalBloombergPolitico, Washington Post, Government ExecutiveTreatment Magazine, and Associated Press.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by HHS, FNS, PTO, FDA, and NCUA. Plus other notable actions by DOI, SSA, DHS, USCIS, HHS, and CFPB.

With opinions and analysis from Mark Febrizio, Scott Gottlieb, Tyler Cowen, Christina Parajon Skinner, Jeffrey Singer, Danielle Butcher, Holman Jenkins, Liza Reed, Cass Sunstein, Scott Wallsten, Shane Tews, Darya Minovi, Randy May, Adam Thierer, and Liya Palagashvili.

Plus news from AxiosThe HillNew York TimesReutersWall Street JournalAssociated PressBloomberg, and E&E News.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CFPB, ED, FCC, CDC, and CLA. Plus other notable actions by CFTC, CPSC, and DOE.

With opinions and analysis from Steven Balla, Bridget Dooling, Daniel Pérez, Edward Glaeser, Cary Coglianese, Kofi Ampaabeng, Elizabeth Nolan Brown, Robert Graboyes, Roslyn Layton, Beth Garza, Ilya Somin, James Broughel, Arther Fraas, Randall Lutter, Heather Reams, Jennifer Huddleston, Judge Glock, and Ellen Wald.

Plus news from Los Angeles TimesThe HillNew York TimesReutersWall Street JournalBloomberg, and E&E News.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by FDA, HUD, and CLA. Plus other notable actions by DOT, CPSC, HUD, EPA, and ETA.

With opinions and analysis from Daniel Pérez, Christopher Carrigan, Stuart Shapiro, Utsha Khatri, Elizabeth Samuels, Richard Schmalensee, David Schoenbrod, Eugene Volokh, James Capretta, Greg Ip, Ilya Somin, Dan Farber, Tom Wheeler, and Ashley Johnson.

Plus news from Government ExecutiveThe HillNew York TimesRegulatory FocusWall Street JournalBloomberg, and E&E News.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by the CDC and NOAA. Plus other notable actions by DOE, DOL, and EPA.

With opinions and analysis from Sally Katzen, Leah Brooks, Jonathan Adler, Randy May, Ilya Somin, Caleb Watney, Liya Palagashvili, Andy Kessler, Dan Farber, Osub Ahmed, and Tom Wheeler.

Plus news from NPRThe HillNew York TimesAssociated PressWall Street JournalBloombergWashington Post, and Daily Beast.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by FCC, DHS, CBP, SBA, and HUD. Plus other notable actions by EPA, HHS< DHS, FCC, DOE, and CFPB.

With opinions and analysis from Susan Dudley, Steven Balla, Bridget Dooling, Daniel Pérez, Brandon Dorfman, Greg Ip, Scott Gottlieb, James Capretta, Jonathan Adler, Susan Tierney, Rachel Sachs, Daniel Walters, and Dan Bosch.

Plus news from The HillNew York TimesAssociated PressWall Street JournalBloombergWashington Post, The VergeReuters, and NBC.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 from ED, GSA, HHS, FEMA, & DHS; plus other notable actions from EPA, USDA, EPA, & DOL.

With opinions and analysis from Richard Pierce, Randall Lutter, Jonathan Turley, Ilya Somin, Robert Graboyes, Darcy Nikol Bryan, Wayne Crews, Sally Pipes, Andrea O'Sullivan, Jennifer Huddleston, Tom Wheeler, Richard Morrison, and others.

Plus news from The HillNPRNew York TimesWall Street JournalPoliticoReutersE&E News, and USA Today.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by HHS and SBA. Plus other notable actions by USDA, HHS, DOL, and NHTSA.

With opinions and analysis from Bridget Dooling, Laura Stanley, Mark Febrizio, Leah Brooks, Nick Hart, Sanjay Pandey, Michael Greenstone, Ian Jefferies, Tyler Cowen, Liya Palagashvili, Michael Farren, Arielle Kane, Brian Knight, Matthew Mitchell, Ryan Bourne, and James Broghel.

Plus news from The HillNew York TimesWall Street JournalBloombergWashington Post, NPRReuters, and CNBC.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by FRA, DHS, and CLA. Plus other notable actions by President Biden, the FDIC, FCC, NOAA, and SEC.

With opinions and analysis from Bridget Dooling, Susan Dudley, Tyler Cowen, Richard Revesz, James Broughel, Roslyn Layton, Connor Raso, Aaron Klein, Randall Lutter, Ilya Somin, Adam Thierer, John Chorssen, Robert Graboyes, Patrick McLaughlin, Sidney Shapiro, Wayne Crews, and Dan Farber.

Plus news from The HillNew York TimesWall Street JournalBloombergWashington Post, Reuters, and Law 360.

 

 


 

The Regulatory Studies Center Update

 

A monthly(ish) collection of working papers, events, op-eds, and insights.

 

SUBSCRIBE TODAY!

Most recent edition...

 

 

March 2021

This update features our recent report by Bridget Dooling and Laura Stanley Telemedicine & Initiating Buprenorphine Treatment, which is part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project.  It also includes scholarly articles by Susan Dudley on President Biden's early executive actions, Jerry Ellig on surface freight deregulation, and Bridget Dooling on GAO's role in the administrative state and her innovative research on bespoke regulatory review.

There is also an analysis of regulatory sentiment by Zhoudan Xie, a reflection on the year that was 2020 by Mark Febrizioi and Zhoudan Xie, opioid treatment waivers by Laura Stanley, and advice for the Biden-Harris administration from Richard J. Pierce, Jr. and Susan Dudley.

Plus various op-eds in the Wall Street Journal, The Hill, Forbes, and Government Executive, events with American Economic Association, Federalist Society, and Southern Economic Association, and quotes in popular media outlets, including the Wall Street JournalFederal News Network, Science, Bloomberg, USA Today, and Axios.

Previous editions

FULL NEWSLETTER

This update features our recent Delivering the Goods event with analysis from STB general counsel Craig Keats and UW-Milwaukee professor James Peoples, and includes scholarly articles by Bridget Dooling on the Administrative Procedure Act, Brian Mannix on the EPA's 50th anniversary, and Aryamala Prasad & Daniel Pérez on the effects of GDPR.

There is also an analysis of FCC spectrum auctions by Gerald Brock, and public interest comments related to immigration policies from DHS by Mark Febrizio, OPM's paid parental leave by Joseph Cordes & Jerry Ellig, and a Section 230 petition by Jerry Ellig.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the Wall Street JournalNew York Times, The Hill, Bloomberg, Forbes, PoliticoReutersAudubon MagazineGovernment Executive, and Law360.

FULL NEWSLETTER

This update includes scholarly articles by Susan Dudley on the durability of OIRA's regulatory oversight, Bridget Dooling on a new concept for independent agency rulemaking called Bespoke Regulatory Review, Jerry Ellig on how to improve economic analysis at federal agencies, and Zhoudan Xie's review of regulations and news coverage during the COVID-19 pandemic.

There are also public interest comments on a recent EPA proposal by Brian Mannix and Joe Cordes, a review of the Spring Unified Agenda by Daniel Pérez, and Mark Febrizio provides a full analysis of the Trump Administration's regulatory budget.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the New York Times, The Hill, Bloomberg, Forbes, Politifact, and Vox.

FULL NEWSLETTER

This update includes public interest comments to the DEA, DOT, FDA, and USDA from Laura Stanley, John Bertino, and Mark Febrizio.

Academic papers by Susan Dudley, Zhoudan Xie, and Steven Balla, plus articles published by the Brookings Institution and The Regulatory Review. And a four-chapter report based on a co-operative agreement with the USDA.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the Washington Post, The Hill, Bloomberg, Forbes, and CQ Roll Call.

FULL NEWSLETTER

This update includes testimony before the House Financial Services Subcommittee on Oversight and Investigations, and the General Services Administration by Steven Balla.

Academic papers by Bridget Dooling, Jerry Ellig, Chris Carrigan, Mark Febrizio, and Susan Dudley, and public interest comments submitted to the Surface Transportation Board, Council on Environmental Quality, the Office of Management and Budget, and the Federal Deposit Insurance Corporation.

Plus various commentaries, op-eds, and quotes in popular media outlets, including Federal News Network, The Hill, E&E News, Forbes, and Government Executive.

FULL NEWSLETTER

This update includes an announcement about our 10th anniversary at GW, #RegStudies10!

We feature research from our scholars published by Brookings, the Public Administration Review, and the Review of Austrian Economics journal.

There is also a working paper by Chris Carrigan, Jerry Ellig, and Zhoudan Xie, as well as Mark Febrizio and Susan Dudley's Regulators' Budget report with Melinda Warren from the Weidenbaum Center.

Plus various commentaries, op-eds, and quotes in popular media outlets like The Wall Street Journal, The Hill, Bloomberg, Forbes, Government Executive, Law 360, and Health Affairs.